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THE effect of interleukin-6 (IL-6) on gene expression of
extracellular matrix components in bovine mesangial cells
in culture has been investigated. IL-6 (100 U/ml) time
dependently increased the steady state expression of
mRNAs coding for 1 collagen III and fibronectin,
both transcripts being 1.5- and 2.5-fold higher than basal
level at 24 and 48h, respectively. In contrast, IL-6
stimulated laminin mRNA expression only after 48 h
incubation (2.5-fold upon basal level). These results
suggest that IL-6 could favour glomerular matrix
accumulation thus contributing to the development of
glomerulosclerosis.
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Accumulation of extracellular matrix and prolif-
eration of intrinsic glomerular cells are abnormali-
ties common to several forms of glomerular diseases
which might contribute to renal disease pro-
gression. 1’2 The generation of extracellular matrix
is at least, in part, regulated by cytokines and
growth factors produced by infiltrating or resident
cells in the glomerulus. Thus transforming growth
factor fl (TGF/) and platelet-derived growth factor
(PDGF) have been recognized as possible modula-
tors of matrix protein synthesis by glomerular cells
contributing to increased matrix formation in
experimental glomerulonephritis.
>7
Among other cytokines, interleukin-6 (IL-6) has
very interesting potential as a new mediator of
glomerular injury and disease progression. IL-6 is
a pleiotropic cytokine that acts on a wide range of
tissues, exerting growth-inducing, growth-inhibi-
tory and differentiation-inducing effects, depending
on the nature of the target cells, Originally
described as a product of activated monocytes and
lymphocytes, IL-6 is synthesized by many cell types
including glomerular mesangial cells.
The authors have recently shown that human
mesangial cells in culture stimulated with inter-
leukin-1 (IL-1) and tumour necrosis factor, unlike
resting mesangial cells, express IL-6 gene and
release the corresponding protein in the super-
natant.
9 Other authors have reported the capability
of unstimulated rat mesangial cells to secrete and to
proliferate in response to exogenously added IL-6.1
Thus a role of IL-6 as an autocrine growth factor
for mesangial cells was proposed.
1 In keeping with
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this possibility are recent clinical data showing an
increased urinary excretion of IL-6 in patients with
mesangial proliferative glomerulonephritis.
11 More-
over experimental studies have documented that
IL-6 transgenic mice, carrying a human IL-6
genomic gene fused with human immunoglobulin
heavy chain enhancer, had high serum IL-6,
proteinuria, and mesangial proliferative glomer-
ulonephritis
12 and that treatment with anti-human
IL-6 antibody prevented mesangial cell prolifera-
tion.
3 In the experimental model of lupus nephritis
in mice it has been shown that the administration
of recombinant IL-6 accelerated the development of
the autoimmune glomerulonephritis.
14 However,
whether IL-6 has indeed mitogenic properties on
mesangial cells is still a very controversial issue
considering that in other recent experiments IL-6
inhibits rather than stimulates the growth of
mesangial cells in culture.s The in vivo finding that
pretreatment with IL-6 reduces albumin excretion
in a rat model of nephrotoxic nephritis
16 is
consistent with the possibility that IL-6, by
inhibiting mesangial growth, protects against
glomerular damage. Since cultured mesangial cells
constitutively express the 80 kDa IL-6 receptor and
the IL-6 signal transducer, gp 130,17 the authors
explored whether IL-6 regulated gene expression
of extracellular matrix components in bovine
mesangial cells in culture.
Methods
Mesangial cell cultures" Mesangial cells were obtained
from collagenase treated isolated bovine glomeruli
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as described previously.
TM Cells were cultured in
RPMI 1640 medium (Gibco, Grand Island, NY)
supplemented with 20 mM Hepes (Sigma Chemical
Company, St. Louis, MO), 2mM glutamine
(Gibco), 100 units/ml penicillin, 100 #g/ml of
streptomycin, 250 ng/ml of fungizone and 20%
foetal calf serum (Gibco). Confluent cells were
passed by washing with Ca2+-free, Mg2+-free
Hank’s balanced solution followed by incubation
with 0.05% trypsin/0.02% ethylenediaminetetraace-
tic acid and resuspension in complete RPMI 1640
medium. Cells were used between passages 10 to
13. Ceils were identified by phase contrast
microscopy and by staining for intermediate
filaments as described previously
TM (Fig. 1A and B).
Experimental design: Confluent bovine mesangial cells
grown in 100 mm plastic dishes were kept under
serum-free conditions for 48 h. Cells deprived of
serum were incubated in the presence or absence of
human recombinant IL-6 (100 U/ml; provided by
Dr S. Gillis, Immunex, Seattle, WA) for different
time intervals. At the end of the incubation, the
cells were used for total cellular RNA preparation
in order to study 01 collagen III, fibronectin and
laminin gene expression.
Preparation of total cellular RNA and Northern blot analysis:
Total cellular RNA was isolated from bovine
FIG. 1. Phase contrast micrograph of bovine mesangial cells in culture
stained by indirect immunofluorescence for the intermediate filaments
desmin (A) or vimentin (B).
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mesangial cells as described previously
9 by lysing
cells in guanidium isothiocyanate and recovering
RNA by centrifugation through caesium chloride.
Seven-microgram samples were then fractionated
on a 0.7% agarose gel with 6% formaldehyde and
blotted onto .synthetic membranes (Gene Screen
Plus, New England Nuclear, Boston, MA). All gels
were stained with ethidium bromide to visualize
28S and 18S ribosomal RNA bands. These bands
were used to confirm that (a) approximately
equivalent amounts of RNA were loaded in each
gel lane, and (b) there was no obvious degradation
of RNA. cDNA probes for human 1 collagen II1
(gift of Dr R. Nischt, Dermatologische Klinik der
Universitat, Koln, Germany), human fibronectin
(purchased from HGMP Resource Centre, Harrow,
Middx, UK) and mouse laminin (gift of Dr I.
Oberbaumer, Max Planck Institut fur Biochemie,
Munich, Germany) were labelled to a specific
activity of 109 cpm//g by using hexanucleotide
primers and 32p-dCTp.2
Hybridization was performed for 20 h at 60C in
a solution containing I M NaC1, 1% sodium dodecyl
sulfate (SDS), 10% dextran sulfate, 100/g/ml
salmon sperm DNA, and 1 x 106 cpm/ml labelled
probe as described previously.
9 The membranes
were washed with 1 x standard saline citrate
(SSC)/1% SDS for 1 h at 60C and 0.1 x SSC at
room temperature for 1 h (1 x SSC 0.15 M NaC1
and 0.015 M Na citrate, pH 7.0). The blots were
then dried and used to expose Kodak Xomat X-ray
film with intensifying screens. Membranes were
subsequently rehybridized with rat GAPDH cDNA
as ’housekeeping gene’ to determine an internal
standard of total RNA content. After optimal
exposure, the autoradiographs of each experiment
were scanned by a laser densitometer in order to
quantify the relative amounts of radioactively
labelled probe bound for each transcript. 1.
collagen III, fibronectin and laminin mRNA optical
density was normalized to that of the constituently
released GAPDH gene expression.
Results
In a first series of experiments the effect of IL-6
on the steady state level of 1 collagen III specific
mRNA in bovine mesangial cells after 3, 6, 24 and
48 h incubation (Fig. 2) was measured. Densito-
metric analysis of the autoradiographic signals
showed that in unstimulated mesangial cells
collagen type II1 transcript levels were comparable
during all the observation time. In mesangial cells
stimulated with IL-6 transcriptional rates of
collagen 11I gene were comparable with those of
resting ceils after 3 and 6 h incubation. An increase
in collagen II1 gene expression was observed after
24 and 48 h of IL-6 stimulation, the mRNA levelsIL-6 and extracellular matrix components
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being 1.5- and 2.5-fold higher than corresponding
unstimulated control cells, respectively. Similar
results were obtained in a next series of experiments
when the effect of IL-6 on fibronectin mRNA was
tested (Fig. 3). Starting 24 h after addition of IL-6
a 1.5-fold increase in fibronectin specific mRNA
levels was observed. A maximal increase (2.5-fold
FIG. 2. Northern blot analysis of 1 collagen III mRNA
18 S from cultured bovine mesangial cells (MC) exposed
for 3, 6, 24 and 48 h to medium alone or IL-6
(100 U/ml). Blots are representative of three in-
GAPDH dividual experiments. The same membrane was
rehybridized to the GAPDH probe. Inset: ethidium
bromide stain of RNA.
over unstimulated control cells) was seen after 48 h.
In untreated mesangial cells the level of fibronectin
specific mRNA did not change with time. Finally,
we investigated whether IL-6 also stimulated
laminin mRNA in bovine mesangial cells. Figure 4
shows that IL-6 did not change laminin mRNA
levels in mesangial cells after 6 and 24 h incubation.
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FIG. 3. Fibronectin mRNA expression in cultured GAPDH bovine mesangial cells (MC). Data shown are from a
representative experiment (n 3). Total cellular RNA
was isolated after incubation of cells with medium
alone or IL-6 (100 U/ml) for different time intervals.
The same membrane was rehybridized to the GAPDH
probe. Inset: ethidium bromide stain of RNA.
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FIG. 4. Laminin mRNA expression in cultured bovine
mesangial cells (MC) incubated for 6, 24 and 48 h with
medium alone or IL-6 (100 U/ml). Data shown are from
representative experiment (n 3). The same membrane was
rehybridized to the GAPDH probe. Inset: ethidium bromide
stain of RNA.
IL-6 increased laminin mRNA expression only after
48 h incubation. At this time densitometric analysis
revealed a 2.5-fold increase of laminin transcripts in
IL-6 stimulated cells compared with control cells.
Discussion
The present data show that IL-6 time de-
pendently increases gene expression of extracellular
matrix components in bovine mesangial cells and
indicate that IL-6 could directly affect accumulation
of glomerular extracellular matrix. The stimulation
of the extracellular matrix by IL-6 has been reported
previously for cell types other than mesangial cells.
Lanser and Brown
21 showed that IL-6 directly
stimulated fibronectin production by rat hepato-
cytes in a dose-dependent manner.
Increased deposition of extracellular matrix
components within the glomerulus is considered a
major determinant of glomerulosclerosis.
2 The
process of glomerular accumulation of the extra-
cellular matrix may be affected by a variety of
factors that are active either at the level of
extracellular matrix generation or degradation.
Experimental studies have greatly contributed to.
the clarification of the role of cytokines and growth
factors in the modulation of the amount of
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deposited extracellular matrix. Thus polypeptide
mediators like TGFfl, PDGF and 1L-1 have been
shown to stimulate both extracellular matrix protein
production or degradation through the activation
of proteinases.
22-)4 In some instances, also the
distribution of matrix proteins can be altered
during glomerular disease. Immunohistochemical
and biochemical studies have demonstrated that in
normal conditions major components of mesangial
matrix include collagen IV, fibronectin, laminin,
entactin/nidogen and proteoglycans. In diseased
glomeruli also the insterstitial collagens I and III
have been localized. 25’26 These collagens are scarce
or undetectable in normal glomeruli of laboratory
animals and humans. However studies with
cultured mesangial ceils have shown that mRNA of
collagens I and III are expressed and translated into
secreted proteins. 23’27 Thus, it is likely that in
glomerular diseases mesangial cells are a source of
collagens and other extracellular matrix proteins
that accumulate, resulting in mesangial and
glomerular scarring. The finding that IL-6 enhances
gene expression of extracellular matrix proteins in
mesangial cells suggests that this cytokine by
promoting extracellular matrix deposition could
play a role in the processes leading to glomerulo-
sclerosis.IL-6 and extracellular matrix components
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